25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Yifeng Pharmacy
Buy, Hold or Sell?

Let's analyze Yifeng Pharmacy together

I guess you are interested in Yifeng Pharmacy. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Yifeng Pharmacy. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Yifeng Pharmacy

I send you an email if I find something interesting about Yifeng Pharmacy.

1. Quick Overview

1.1. Quick analysis of Yifeng Pharmacy (30 sec.)










1.2. What can you expect buying and holding a share of Yifeng Pharmacy? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
76.9%

What is your share worth?

Current worth
¥9.00
Expected worth in 1 year
¥9.91
How sure are you?
97.4%

+ What do you gain per year?

Total Gains per Share
¥1.31
Return On Investment
5.0%

For what price can you sell your share?

Current Price per Share
¥26.47
Expected price per share
¥20.80 - ¥35.93
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Yifeng Pharmacy (5 min.)




Live pricePrice per Share (EOD)
¥26.47
Intrinsic Value Per Share
¥54.84 - ¥64.92
Total Value Per Share
¥63.83 - ¥73.92

2.2. Growth of Yifeng Pharmacy (5 min.)




Is Yifeng Pharmacy growing?

Current yearPrevious yearGrowGrow %
How rich?$1.5b$1.3b$186.8m12.5%

How much money is Yifeng Pharmacy making?

Current yearPrevious yearGrowGrow %
Making money$52.9m$49m$3.8m7.3%
Net Profit Margin6.3%6.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Yifeng Pharmacy (5 min.)




2.4. Comparing to competitors in the Pharmaceutical Retailers industry (5 min.)




  Industry Rankings (Pharmaceutical Retailers)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Yifeng Pharmacy?

Welcome investor! Yifeng Pharmacy's management wants to use your money to grow the business. In return you get a share of Yifeng Pharmacy.

First you should know what it really means to hold a share of Yifeng Pharmacy. And how you can make/lose money.

Speculation

The Price per Share of Yifeng Pharmacy is ¥26.47. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Yifeng Pharmacy.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Yifeng Pharmacy, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥9.00. Based on the TTM, the Book Value Change Per Share is ¥0.23 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Yifeng Pharmacy.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.050.2%0.040.2%0.040.2%0.030.1%0.020.1%
Usd Book Value Change Per Share-0.02-0.1%0.030.1%0.040.2%0.040.1%0.030.1%
Usd Dividend Per Share0.040.1%0.010.1%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.020.1%0.050.2%0.050.2%0.050.2%0.040.1%
Usd Price Per Share3.46-4.91-7.34-8.58-7.55-
Price to Earnings Ratio19.03-28.57-45.69-86.42-145.36-
Price-to-Total Gains Ratio202.11-125.64-138.47-257.61-373.80-
Price to Book Ratio2.73-4.00-6.84-11.08-17.64-
Price-to-Total Gains Ratio202.11-125.64-138.47-257.61-373.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.726976
Number of shares268
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.030.04
Usd Total Gains Per Share0.050.05
Gains per Quarter (268 shares)12.3712.27
Gains per Year (268 shares)49.4749.08
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
115343994039
2306988188088
34510313727120137
46013818636160186
57517223545200235
69020728454240284
710524133364280333
812027538273320382
913531043182360431
1015034448091400480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.00.0100.0%40.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%36.03.00.092.3%36.03.01.090.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%30.00.09.076.9%30.00.010.075.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%38.01.00.097.4%38.01.01.095.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Yifeng Pharmacy compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1310.228-157%0.302-143%0.265-149%0.231-157%
Book Value Per Share--8.9968.750+3%7.657+17%6.480+39%4.394+105%
Current Ratio--1.2221.160+5%1.091+12%1.274-4%0.853+43%
Debt To Asset Ratio--0.5870.569+3%0.550+7%0.535+10%0.459+28%
Debt To Equity Ratio--1.5211.410+8%1.307+16%1.228+24%0.942+62%
Dividend Per Share--0.2530.100+153%0.086+194%0.060+320%0.042+496%
Eps--0.3220.310+4%0.294+10%0.223+45%0.146+122%
Free Cash Flow Per Share--0.9040.879+3%0.761+19%0.460+96%0.253+257%
Free Cash Flow To Equity Per Share--0.9040.879+3%0.363+149%0.322+180%0.308+194%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--64.920--------
Intrinsic Value_10Y_min--54.835--------
Intrinsic Value_1Y_max--3.185--------
Intrinsic Value_1Y_min--3.127--------
Intrinsic Value_3Y_max--12.101--------
Intrinsic Value_3Y_min--11.502--------
Intrinsic Value_5Y_max--24.068--------
Intrinsic Value_5Y_min--22.121--------
Market Cap32093817047.040+7%29765893785.60042286219284.890-30%63175260278.861-53%73860987487.754-60%64983064710.289-54%
Net Profit Margin--0.0680.063+6%0.063+7%0.060+13%0.061+10%
Operating Margin----0%0.069-100%0.068-100%0.045-100%
Operating Ratio--1.4931.520-2%1.508-1%1.513-1%1.185+26%
Pb Ratio2.943+7%2.7293.996-32%6.843-60%11.080-75%17.644-85%
Pe Ratio20.522+7%19.03428.570-33%45.690-58%86.422-78%145.359-87%
Price Per Share26.470+7%24.55034.873-30%52.105-53%60.918-60%53.596-54%
Price To Free Cash Flow Ratio7.324+7%6.79311.859-43%409.794-98%124.992-95%160.485-96%
Price To Total Gains Ratio217.920+7%202.113125.636+61%138.466+46%257.612-22%373.801-46%
Quick Ratio--0.4480.355+26%0.257+74%0.305+47%0.307+46%
Return On Assets--0.0150.015-3%0.017-12%0.016-5%0.017-15%
Return On Equity--0.0380.038+2%0.040-4%0.036+8%0.034+13%
Total Gains Per Share--0.1210.328-63%0.388-69%0.325-63%0.273-56%
Usd Book Value--1535695713.4761493932393.337+3%1307113691.242+17%1106230392.325+39%750052649.645+105%
Usd Book Value Change Per Share---0.0180.032-157%0.042-143%0.037-149%0.032-157%
Usd Book Value Per Share--1.2671.232+3%1.078+17%0.912+39%0.619+105%
Usd Dividend Per Share--0.0360.014+153%0.012+194%0.008+320%0.006+496%
Usd Eps--0.0450.044+4%0.041+10%0.031+45%0.020+122%
Usd Free Cash Flow--154248598.781150004457.428+3%129898773.079+19%78522340.215+96%43175917.658+257%
Usd Free Cash Flow Per Share--0.1270.124+3%0.107+19%0.065+96%0.036+257%
Usd Free Cash Flow To Equity Per Share--0.1270.124+3%0.051+149%0.045+180%0.043+194%
Usd Market Cap4518809440.223+7%4191037845.0125953899675.313-30%8895076647.264-53%10399627038.276-60%9149615511.209-54%
Usd Price Per Share3.727+7%3.4574.910-30%7.336-53%8.577-60%7.546-54%
Usd Profit--55047876.09952960146.129+4%49080722.142+12%37785056.326+46%24726412.872+123%
Usd Revenue--815440088.483832271105.800-2%768870974.390+6%619067564.041+32%404058013.165+102%
Usd Total Gains Per Share--0.0170.046-63%0.055-69%0.046-63%0.038-56%
 EOD+4 -4MRQTTM+23 -11YOY+23 -125Y+22 -1310Y+22 -13

3.3 Fundamental Score

Let's check the fundamental score of Yifeng Pharmacy based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.522
Price to Book Ratio (EOD)Between0-12.943
Net Profit Margin (MRQ)Greater than00.068
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.448
Current Ratio (MRQ)Greater than11.222
Debt to Asset Ratio (MRQ)Less than10.587
Debt to Equity Ratio (MRQ)Less than11.521
Return on Equity (MRQ)Greater than0.150.038
Return on Assets (MRQ)Greater than0.050.015
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Yifeng Pharmacy based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose25.520
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Yifeng Pharmacy

Yifeng Pharmacy Chain Co., Ltd. engages in the retail of pharmaceutical products in China. It also offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices, health supplements, personal care products, and convenience products related to health. The company operates pharmaceutical chain stores in Hunan, Hubei, Shanghai, Jiangsu, Jiangxi, Zhejiang, Guangdong, Hebei, Beijing, and Tianjin. Yifeng Pharmacy Chain Co., Ltd. was founded in 2001 and is headquartered in Changsha, China.

Fundamental data was last updated by Penke on 2024-10-31 17:20:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Yifeng Pharmacy earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Yifeng Pharmacy to the Pharmaceutical Retailers industry mean.
  • A Net Profit Margin of 6.8% means that ¥0.07 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Yifeng Pharmacy:

  • The MRQ is 6.8%. The company is making a profit. +1
  • The TTM is 6.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.8%TTM6.3%+0.4%
TTM6.3%YOY6.3%+0.0%
TTM6.3%5Y6.0%+0.4%
5Y6.0%10Y6.1%-0.1%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ6.8%1.0%+5.8%
TTM6.3%0.7%+5.6%
YOY6.3%1.0%+5.3%
5Y6.0%1.6%+4.4%
10Y6.1%1.5%+4.6%
4.3.1.2. Return on Assets

Shows how efficient Yifeng Pharmacy is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Yifeng Pharmacy to the Pharmaceutical Retailers industry mean.
  • 1.5% Return on Assets means that Yifeng Pharmacy generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Yifeng Pharmacy:

  • The MRQ is 1.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.5%0.0%
TTM1.5%YOY1.7%-0.2%
TTM1.5%5Y1.6%0.0%
5Y1.6%10Y1.7%-0.2%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%0.4%+1.1%
TTM1.5%0.4%+1.1%
YOY1.7%0.3%+1.4%
5Y1.6%0.3%+1.3%
10Y1.7%0.3%+1.4%
4.3.1.3. Return on Equity

Shows how efficient Yifeng Pharmacy is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Yifeng Pharmacy to the Pharmaceutical Retailers industry mean.
  • 3.8% Return on Equity means Yifeng Pharmacy generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Yifeng Pharmacy:

  • The MRQ is 3.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.8%TTM3.8%+0.1%
TTM3.8%YOY4.0%-0.2%
TTM3.8%5Y3.6%+0.2%
5Y3.6%10Y3.4%+0.2%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8%1.4%+2.4%
TTM3.8%1.0%+2.8%
YOY4.0%1.6%+2.4%
5Y3.6%1.8%+1.8%
10Y3.4%0.8%+2.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Yifeng Pharmacy.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Yifeng Pharmacy is operating .

  • Measures how much profit Yifeng Pharmacy makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Yifeng Pharmacy to the Pharmaceutical Retailers industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Yifeng Pharmacy:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY6.9%-6.9%
TTM-5Y6.8%-6.8%
5Y6.8%10Y4.5%+2.3%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.7%-2.7%
TTM-1.4%-1.4%
YOY6.9%1.5%+5.4%
5Y6.8%1.4%+5.4%
10Y4.5%1.3%+3.2%
4.3.2.2. Operating Ratio

Measures how efficient Yifeng Pharmacy is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • An Operation Ratio of 1.49 means that the operating costs are ¥1.49 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Yifeng Pharmacy:

  • The MRQ is 1.493. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.520. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.493TTM1.520-0.027
TTM1.520YOY1.508+0.012
TTM1.5205Y1.513+0.007
5Y1.51310Y1.185+0.328
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4931.493+0.000
TTM1.5201.246+0.274
YOY1.5081.147+0.361
5Y1.5131.174+0.339
10Y1.1851.185+0.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Yifeng Pharmacy.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Yifeng Pharmacy is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A Current Ratio of 1.22 means the company has ¥1.22 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Yifeng Pharmacy:

  • The MRQ is 1.222. The company is just able to pay all its short-term debts.
  • The TTM is 1.160. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.222TTM1.160+0.062
TTM1.160YOY1.091+0.069
TTM1.1605Y1.274-0.114
5Y1.27410Y0.853+0.420
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2221.259-0.037
TTM1.1601.270-0.110
YOY1.0911.161-0.070
5Y1.2741.315-0.041
10Y0.8531.443-0.590
4.4.3.2. Quick Ratio

Measures if Yifeng Pharmacy is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Yifeng Pharmacy to the Pharmaceutical Retailers industry mean.
  • A Quick Ratio of 0.45 means the company can pay off ¥0.45 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Yifeng Pharmacy:

  • The MRQ is 0.448. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.355. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.448TTM0.355+0.093
TTM0.355YOY0.257+0.098
TTM0.3555Y0.305+0.050
5Y0.30510Y0.307-0.003
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4480.505-0.057
TTM0.3550.546-0.191
YOY0.2570.536-0.279
5Y0.3050.641-0.336
10Y0.3070.881-0.574
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Yifeng Pharmacy.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Yifeng Pharmacy assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Yifeng Pharmacy to Pharmaceutical Retailers industry mean.
  • A Debt to Asset Ratio of 0.59 means that Yifeng Pharmacy assets are financed with 58.7% credit (debt) and the remaining percentage (100% - 58.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Yifeng Pharmacy:

  • The MRQ is 0.587. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.569. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.587TTM0.569+0.019
TTM0.569YOY0.550+0.018
TTM0.5695Y0.535+0.033
5Y0.53510Y0.459+0.077
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5870.638-0.051
TTM0.5690.651-0.082
YOY0.5500.690-0.140
5Y0.5350.640-0.105
10Y0.4590.600-0.141
4.5.4.2. Debt to Equity Ratio

Measures if Yifeng Pharmacy is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Yifeng Pharmacy to the Pharmaceutical Retailers industry mean.
  • A Debt to Equity ratio of 152.1% means that company has ¥1.52 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Yifeng Pharmacy:

  • The MRQ is 1.521. The company is just able to pay all its debts with equity.
  • The TTM is 1.410. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.521TTM1.410+0.111
TTM1.410YOY1.307+0.103
TTM1.4105Y1.228+0.181
5Y1.22810Y0.942+0.287
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5211.607-0.086
TTM1.4101.745-0.335
YOY1.3072.145-0.838
5Y1.2281.982-0.754
10Y0.9421.661-0.719
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Yifeng Pharmacy generates.

  • Above 15 is considered overpriced but always compare Yifeng Pharmacy to the Pharmaceutical Retailers industry mean.
  • A PE ratio of 19.03 means the investor is paying ¥19.03 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Yifeng Pharmacy:

  • The EOD is 20.522. Based on the earnings, the company is fair priced.
  • The MRQ is 19.034. Based on the earnings, the company is fair priced.
  • The TTM is 28.570. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD20.522MRQ19.034+1.489
MRQ19.034TTM28.570-9.537
TTM28.570YOY45.690-17.120
TTM28.5705Y86.422-57.852
5Y86.42210Y145.359-58.937
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD20.52210.142+10.380
MRQ19.03412.431+6.603
TTM28.5709.431+19.139
YOY45.69011.917+33.773
5Y86.4226.490+79.932
10Y145.35914.310+131.049
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Yifeng Pharmacy:

  • The EOD is 7.324. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.793. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 11.859. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.324MRQ6.793+0.531
MRQ6.793TTM11.859-5.066
TTM11.859YOY409.794-397.935
TTM11.8595Y124.992-113.133
5Y124.99210Y160.485-35.493
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD7.3242.404+4.920
MRQ6.7932.425+4.368
TTM11.8592.438+9.421
YOY409.7943.326+406.468
5Y124.9922.868+122.124
10Y160.4850.118+160.367
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Yifeng Pharmacy is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A PB ratio of 2.73 means the investor is paying ¥2.73 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Yifeng Pharmacy:

  • The EOD is 2.943. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.729. Based on the equity, the company is underpriced. +1
  • The TTM is 3.996. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.943MRQ2.729+0.213
MRQ2.729TTM3.996-1.267
TTM3.996YOY6.843-2.847
TTM3.9965Y11.080-7.083
5Y11.08010Y17.644-6.564
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD2.9431.134+1.809
MRQ2.7291.284+1.445
TTM3.9961.466+2.530
YOY6.8431.299+5.544
5Y11.0801.919+9.161
10Y17.6442.980+14.664
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets26,436,820
Total Liabilities15,529,891
Total Stockholder Equity10,209,293
 As reported
Total Liabilities 15,529,891
Total Stockholder Equity+ 10,209,293
Total Assets = 26,436,820

Assets

Total Assets26,436,820
Total Current Assets13,934,437
Long-term Assets12,502,383
Total Current Assets
Cash And Cash Equivalents 4,188,079
Short-term Investments 3,151,063
Net Receivables 1,954,218
Inventory 3,769,924
Other Current Assets 296,584
Total Current Assets  (as reported)13,934,437
Total Current Assets  (calculated)13,359,867
+/- 574,570
Long-term Assets
Property Plant Equipment 6,066,003
Goodwill 4,747,420
Intangible Assets 484,436
Long-term Assets Other 22,849
Long-term Assets  (as reported)12,502,383
Long-term Assets  (calculated)11,320,709
+/- 1,181,674

Liabilities & Shareholders' Equity

Total Current Liabilities11,406,906
Long-term Liabilities4,122,985
Total Stockholder Equity10,209,293
Total Current Liabilities
Accounts payable 8,083,711
Other Current Liabilities 25,729
Total Current Liabilities  (as reported)11,406,906
Total Current Liabilities  (calculated)8,109,440
+/- 3,297,466
Long-term Liabilities
Long term Debt 1,708,822
Capital Lease Obligations Min Short Term Debt2,342,681
Long-term Liabilities  (as reported)4,122,985
Long-term Liabilities  (calculated)4,051,503
+/- 71,482
Total Stockholder Equity
Retained Earnings 5,066,673
Total Stockholder Equity (as reported)10,209,293
Total Stockholder Equity (calculated)5,066,673
+/- 5,142,621
Other
Capital Stock1,212,453
Common Stock Shares Outstanding 1,212,453
Net Invested Capital 11,918,115
Net Working Capital 2,527,532
Property Plant and Equipment Gross 6,066,003



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-03-312013-12-312012-12-312011-12-31
> Total Assets 
843,407
845,447
1,026,412
0
1,250,951
2,107,777
2,107,191
2,317,938
2,436,690
2,462,774
2,661,069
4,106,340
4,221,246
4,240,703
4,206,359
4,523,483
4,782,560
5,107,283
5,029,821
6,564,482
7,868,143
8,045,929
8,099,390
8,287,643
9,175,278
9,800,626
11,366,030
11,847,659
12,949,901
15,759,608
15,812,175
15,666,203
17,052,037
17,300,656
17,844,900
19,053,207
21,038,887
21,399,379
21,089,323
21,935,279
24,136,539
26,161,824
26,436,820
26,436,82026,161,82424,136,53921,935,27921,089,32321,399,37921,038,88719,053,20717,844,90017,300,65617,052,03715,666,20315,812,17515,759,60812,949,90111,847,65911,366,0309,800,6269,175,2788,287,6438,099,3908,045,9297,868,1436,564,4825,029,8215,107,2834,782,5604,523,4834,206,3594,240,7034,221,2464,106,3402,661,0692,462,7742,436,6902,317,9382,107,1912,107,7771,250,95101,026,412845,447843,407
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,276,003
3,613,997
4,241,831
4,257,007
4,209,719
4,311,743
4,986,055
5,592,506
7,019,416
7,369,638
8,061,799
7,744,556
7,262,101
6,880,030
7,916,017
7,851,012
7,726,573
8,769,589
10,578,223
10,456,653
9,890,572
10,508,691
12,128,911
13,948,585
13,934,437
13,934,43713,948,58512,128,91110,508,6919,890,57210,456,65310,578,2238,769,5897,726,5737,851,0127,916,0176,880,0307,262,1017,744,5568,061,7997,369,6387,019,4165,592,5064,986,0554,311,7434,209,7194,257,0074,241,8313,613,9973,276,003000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
808,068
746,876
1,296,936
1,214,582
1,185,753
1,326,747
1,424,487
1,959,026
2,368,824
2,980,111
3,360,156
2,900,794
2,323,609
2,120,596
2,920,651
2,569,425
2,121,223
3,396,958
4,112,519
3,571,532
2,994,310
3,499,951
3,565,906
5,370,180
4,188,079
4,188,0795,370,1803,565,9063,499,9512,994,3103,571,5324,112,5193,396,9582,121,2232,569,4252,920,6512,120,5962,323,6092,900,7943,360,1562,980,1112,368,8241,959,0261,424,4871,326,7471,185,7531,214,5821,296,936746,876808,068000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
684,470
0
292,760
0
278,940
148,971
193,230
209,250
130,070
5,146
744,841
1,064,243
954,121
765,762
152,188
435,204
231,857
100,881
50,045
1,234,309
925,005
1,100,927
1,630,721
1,605,652
3,151,063
3,151,0631,605,6521,630,7211,100,927925,0051,234,30950,045100,881231,857435,204152,188765,762954,1211,064,243744,8415,146130,070209,250193,230148,971278,9400292,7600684,470000000000000000000
       Net Receivables 
64,236
86,193
118,187
0
154,075
172,541
185,818
208,001
250,543
301,454
313,526
297,376
343,345
371,595
405,942
414,111
478,236
530,794
551,194
700,657
786,970
725,904
637,328
615,240
952,986
967,545
1,021,003
1,010,051
1,064,974
1,138,301
1,179,884
1,163,812
1,400,396
1,602,183
1,801,612
1,593,527
2,291,020
1,285,324
1,912,297
1,619,048
2,138,274
2,356,243
1,954,218
1,954,2182,356,2432,138,2741,619,0481,912,2971,285,3242,291,0201,593,5271,801,6121,602,1831,400,3961,163,8121,179,8841,138,3011,064,9741,010,0511,021,003967,545952,986615,240637,328725,904786,970700,657551,194530,794478,236414,111405,942371,595343,345297,376313,526301,454250,543208,001185,818172,541154,0750118,18786,19364,236
       Other Current Assets 
67,366
75,683
102,889
0
122,408
391,418
146,918
809,840
184,909
476,992
172,752
1,245,223
224,080
1,672,470
190,098
1,680,046
388,732
1,147,921
359,511
1,060,124
424,681
434,771
213,536
275,800
547,458
501,111
546,424
1,445,896
715,651
360,420
333,082
358,890
402,169
449,901
414,034
466,106
466,042
294,568
351,549
271,255
384,124
244,779
296,584
296,584244,779384,124271,255351,549294,568466,042466,106414,034449,901402,169358,890333,082360,420715,6511,445,896546,424501,111547,458275,800213,536434,771424,6811,060,124359,5111,147,921388,7321,680,046190,0981,672,470224,0801,245,223172,752476,992184,909809,840146,918391,418122,4080102,88975,68367,366
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,788,922
3,889,671
3,975,901
4,189,223
4,208,119
4,346,614
4,478,021
4,888,102
8,015,052
8,550,074
8,786,173
9,136,020
9,449,644
10,118,327
10,283,619
10,460,663
10,942,725
11,198,752
11,426,588
12,007,628
12,213,238
12,502,383
12,502,38312,213,23812,007,62811,426,58811,198,75210,942,72510,460,66310,283,61910,118,3279,449,6449,136,0208,786,1738,550,0748,015,0524,888,1024,478,0214,346,6144,208,1194,189,2233,975,9013,889,6713,788,922000000000000000000000
       Property Plant Equipment 
84,703
146,974
150,322
0
165,624
167,498
175,052
241,827
265,452
284,810
292,628
300,308
302,753
305,565
308,266
314,148
315,205
319,936
324,227
406,345
416,581
425,026
448,329
493,839
527,953
544,245
632,643
687,340
812,569
3,834,505
4,187,813
4,323,808
4,504,387
4,643,081
4,807,580
4,759,534
4,891,982
5,021,591
5,133,591
5,342,199
5,665,055
5,844,680
6,066,003
6,066,0035,844,6805,665,0555,342,1995,133,5915,021,5914,891,9824,759,5344,807,5804,643,0814,504,3874,323,8084,187,8133,834,505812,569687,340632,643544,245527,953493,839448,329425,026416,581406,345324,227319,936315,205314,148308,266305,565302,753300,308292,628284,810265,452241,827175,052167,498165,6240150,322146,97484,703
       Goodwill 
0
0
0
0
66,972
66,972
66,972
160,974
284,389
298,215
452,332
539,202
529,229
529,229
598,559
598,559
694,130
945,467
985,331
2,070,002
2,732,803
2,895,468
2,922,081
2,921,531
3,044,912
3,044,912
3,090,692
3,125,692
3,337,704
3,388,004
3,530,504
3,629,827
3,717,890
3,877,311
3,989,264
4,119,214
4,187,924
4,346,544
4,395,164
4,486,528
4,610,549
4,669,000
4,747,420
4,747,4204,669,0004,610,5494,486,5284,395,1644,346,5444,187,9244,119,2143,989,2643,877,3113,717,8903,629,8273,530,5043,388,0043,337,7043,125,6923,090,6923,044,9123,044,9122,921,5312,922,0812,895,4682,732,8032,070,002985,331945,467694,130598,559598,559529,229529,229539,202452,332298,215284,389160,97466,97266,97266,9720000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89,150
37,725
29,554
29,798
30,130
30,407
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000030,40730,13029,79829,55437,72589,150000000000000000000
       Intangible Assets 
108,717
109,107
122,638
0
122,378
120,643
121,537
215,094
338,135
351,261
598,306
684,057
679,367
678,518
769,175
767,803
845,537
1,095,363
150,640
195,037
229,042
253,889
86,719
310,183
355,098
356,613
358,093
365,974
375,260
377,718
381,177
385,788
396,480
400,801
420,130
518,449
485,451
486,336
485,918
488,742
474,469
481,950
484,436
484,436481,950474,469488,742485,918486,336485,451518,449420,130400,801396,480385,788381,177377,718375,260365,974358,093356,613355,098310,18386,719253,889229,042195,037150,6401,095,363845,537767,803769,175678,518679,367684,057598,306351,261338,135215,094121,537120,643122,3780122,638109,107108,717
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,371
63,982
34,925
12,214
10,075
4,955
712,156
58,368
51,509
54,272
21,206
28,387
45,173
232,346
80,371
7,230
9,887
28,460
29,825
30,269
22,012
22,849
22,84922,01230,26929,82528,4609,8877,23080,371232,34645,17328,38721,20654,27251,50958,368712,1564,95510,07512,21434,92563,98217,371000000000000000000000
> Total Liabilities 
487,123
419,627
524,210
0
655,187
745,097
697,165
950,063
1,017,312
990,353
1,126,647
1,198,379
1,245,898
1,195,169
1,182,964
1,437,970
1,602,909
1,813,512
1,715,635
2,934,199
3,698,304
3,692,684
3,619,620
3,671,780
4,466,299
4,860,785
6,050,015
6,326,419
7,167,839
8,480,197
8,410,817
8,027,064
9,187,489
9,147,039
9,507,150
10,466,926
11,917,420
11,774,060
11,288,479
11,916,050
13,689,452
15,093,808
15,529,891
15,529,89115,093,80813,689,45211,916,05011,288,47911,774,06011,917,42010,466,9269,507,1509,147,0399,187,4898,027,0648,410,8178,480,1977,167,8396,326,4196,050,0154,860,7854,466,2993,671,7803,619,6203,692,6843,698,3042,934,1991,715,6351,813,5121,602,9091,437,9701,182,9641,195,1691,245,8981,198,3791,126,647990,3531,017,312950,063697,165745,097655,1870524,210419,627487,123
   > Total Current Liabilities 
386,015
389,884
519,565
0
651,065
741,105
693,305
946,333
1,013,713
986,885
1,080,510
1,152,243
1,200,022
1,149,424
1,137,349
1,392,486
1,557,557
1,768,289
1,670,546
2,559,585
2,898,461
2,893,125
2,820,237
2,931,388
3,725,025
4,119,567
3,960,389
4,280,577
5,137,543
5,903,759
5,731,825
5,578,528
6,745,228
6,824,529
7,014,020
8,041,283
9,659,275
9,635,983
9,050,714
9,695,830
11,269,471
11,088,642
11,406,906
11,406,90611,088,64211,269,4719,695,8309,050,7149,635,9839,659,2758,041,2837,014,0206,824,5296,745,2285,578,5285,731,8255,903,7595,137,5434,280,5773,960,3894,119,5673,725,0252,931,3882,820,2372,893,1252,898,4612,559,5851,670,5461,768,2891,557,5571,392,4861,137,3491,149,4241,200,0221,152,2431,080,510986,8851,013,713946,333693,305741,105651,0650519,565389,884386,015
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,200
31,000
29,000
25,000
29,300
405,319
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000405,31929,30025,00029,00031,00039,20000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,200
31,000
29,000
25,000
29,300
405,319
394,319
380,289
380,319
100,089
0
0
0
3,500
0
500,000
0
0
0
0
0
0
0
0000000500,00003,500000100,089380,319380,289394,319405,31929,30025,00029,00031,00039,20000000000000000000000
       Accounts payable 
283,990
347,036
437,000
0
566,095
655,809
607,004
740,076
815,686
825,258
842,080
922,521
990,538
982,656
872,843
1,125,944
1,238,907
1,348,472
1,235,063
1,772,725
2,200,094
2,304,844
2,200,891
2,406,180
3,018,872
3,040,125
2,782,776
3,123,909
3,821,998
4,033,448
3,798,288
3,856,509
4,805,548
4,685,280
4,618,824
5,159,673
6,760,672
6,681,065
5,959,507
6,723,305
8,170,953
8,003,915
8,083,711
8,083,7118,003,9158,170,9536,723,3055,959,5076,681,0656,760,6725,159,6734,618,8244,685,2804,805,5483,856,5093,798,2884,033,4483,821,9983,123,9092,782,7763,040,1253,018,8722,406,1802,200,8912,304,8442,200,0941,772,7251,235,0631,348,4721,238,9071,125,944872,843982,656990,538922,521842,080825,258815,686740,076607,004655,809566,0950437,000347,036283,990
       Other Current Liabilities 
75,025
42,848
82,565
0
84,969
85,296
86,301
206,257
198,027
161,627
238,429
229,721
209,485
166,768
264,506
266,542
318,650
406,817
271,768
645,383
437,931
39,200
39,200
58,800
321,171
455,590
434,524
477,904
525,070
672,427
659,639
629,525
672,393
788,005
1,063,314
1,010,027
1,016,255
13,653
1,148,814
14,351
22,616
17,046
25,729
25,72917,04622,61614,3511,148,81413,6531,016,2551,010,0271,063,314788,005672,393629,525659,639672,427525,070477,904434,524455,590321,17158,80039,20039,200437,931645,383271,768406,817318,650266,542264,506166,768209,485229,721238,429161,627198,027206,25786,30185,29684,969082,56542,84875,025
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
799,559
799,383
740,392
741,274
741,218
2,089,626
2,045,842
2,030,296
2,576,438
2,678,992
2,448,536
2,442,261
2,322,509
2,493,130
2,425,643
2,258,145
2,138,077
2,237,765
2,220,220
2,419,980
4,005,167
4,122,985
4,122,9854,005,1672,419,9802,220,2202,237,7652,138,0772,258,1452,425,6432,493,1302,322,5092,442,2612,448,5362,678,9922,576,4382,030,2962,045,8422,089,626741,218741,274740,392799,383799,559000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-39,200
-31,000
-29,000
-25,000
-29,300
-405,319
0
0
0
1,895,097
1,997,861
2,068,145
2,024,113
1,904,490
2,052,024
2,030,772
1,951,076
1,883,895
1,963,912
2,052,055
2,205,510
2,236,637
2,342,681
2,342,6812,236,6372,205,5102,052,0551,963,9121,883,8951,951,0762,030,7722,052,0241,904,4902,024,1132,068,1451,997,8611,895,097000-405,319-29,300-25,000-29,000-31,000-39,20000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
744,800
744,800
686,000
687,155
687,278
2,035,890
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002,035,890687,278687,155686,000744,800744,800000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
161,487
188,140
171,336
185,269
191,495
208,705
206,967
208,416
220,416
244,230
267,448
283,095
311,852
347,380
379,594
384,517
405,804
427,892
430,692
0
445,417
0
0
0
0
0000445,4170430,692427,892405,804384,517379,594347,380311,852283,095267,448244,230220,416208,416206,967208,705191,495185,269171,336188,140161,487000000000000000000
> Total Stockholder Equity
354,031
422,635
497,823
502,201
590,384
1,356,886
1,403,637
1,361,022
1,411,697
1,463,972
1,523,798
2,896,458
2,962,508
3,031,862
3,008,498
3,073,885
3,167,203
3,268,161
3,282,225
3,379,798
4,058,761
4,205,930
4,314,276
4,434,469
4,508,308
4,713,565
5,065,326
5,252,695
5,468,672
6,947,379
7,050,416
7,277,400
7,481,306
7,756,449
7,835,040
8,076,269
8,556,079
9,013,838
9,156,657
9,389,513
9,804,432
10,393,859
10,209,293
10,209,29310,393,8599,804,4329,389,5139,156,6579,013,8388,556,0798,076,2697,835,0407,756,4497,481,3067,277,4007,050,4166,947,3795,468,6725,252,6955,065,3264,713,5654,508,3084,434,4694,314,2764,205,9304,058,7613,379,7983,282,2253,268,1613,167,2033,073,8853,008,4983,031,8622,962,5082,896,4581,523,7981,463,9721,411,6971,361,0221,403,6371,356,886590,384502,201497,823422,635354,031
   Common Stock
120,000
120,000
120,000
0
120,000
160,000
160,000
160,000
320,000
320,000
320,000
362,695
362,695
362,695
362,695
362,695
362,695
362,695
362,695
362,695
376,806
376,806
378,923
378,923
378,923
378,923
531,068
531,068
531,518
552,972
718,765
718,765
718,765
718,765
718,610
721,705
721,705
0
1,010,387
0
0
0
0
00001,010,3870721,705721,705718,610718,765718,765718,765718,765552,972531,518531,068531,068378,923378,923378,923378,923376,806376,806362,695362,695362,695362,695362,695362,695362,695362,695362,695320,000320,000320,000160,000160,000160,000120,0000120,000120,000120,000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
220,166
220,166
215,669
0
0
0
62,186
0
-6,004
-42,514
-17,002
0
140,578
0
0
0
0
0000140,5780-17,002-42,514-6,004062,186000215,669220,166220,16600000000000000000000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue22,588,227
Cost of Revenue-13,957,599
Gross Profit8,630,6298,630,629
 
Operating Income (+$)
Gross Profit8,630,629
Operating Expense-20,454,278
Operating Income2,133,949-11,823,649
 
Operating Expense (+$)
Research Development33,550
Selling General Administrative5,636,041
Selling And Marketing Expenses0
Operating Expense20,454,2785,669,591
 
Net Interest Income (+$)
Interest Income93,286
Interest Expense-160,529
Other Finance Cost-18,942
Net Interest Income-86,185
 
Pretax Income (+$)
Operating Income2,133,949
Net Interest Income-86,185
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,037,5942,133,949
EBIT - interestExpense = -160,529
1,411,985
1,572,514
Interest Expense160,529
Earnings Before Interest and Taxes (EBIT)02,198,123
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax2,037,594
Tax Provision-456,663
Net Income From Continuing Ops1,580,9311,580,931
Net Income1,411,985
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net086,185
 

Technical Analysis of Yifeng Pharmacy
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Yifeng Pharmacy. The general trend of Yifeng Pharmacy is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Yifeng Pharmacy's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Yifeng Pharmacy.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 28.07 < 30.90 < 35.93.

The bearish price targets are: 22.60 > 21.94 > 20.80.

Tweet this
Yifeng Pharmacy Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Yifeng Pharmacy. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Yifeng Pharmacy Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Yifeng Pharmacy.

Yifeng Pharmacy Daily Moving Average Convergence/Divergence (MACD) ChartYifeng Pharmacy Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Yifeng Pharmacy. The current adx is .

Yifeng Pharmacy Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Yifeng Pharmacy.

Yifeng Pharmacy Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Yifeng Pharmacy.

Yifeng Pharmacy Daily Relative Strength Index (RSI) ChartYifeng Pharmacy Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Yifeng Pharmacy.

Yifeng Pharmacy Daily Stochastic Oscillator ChartYifeng Pharmacy Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Yifeng Pharmacy.

Yifeng Pharmacy Daily Commodity Channel Index (CCI) ChartYifeng Pharmacy Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Yifeng Pharmacy.

Yifeng Pharmacy Daily Chande Momentum Oscillator (CMO) ChartYifeng Pharmacy Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Yifeng Pharmacy.

Yifeng Pharmacy Daily Williams %R ChartYifeng Pharmacy Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Yifeng Pharmacy.

Yifeng Pharmacy Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Yifeng Pharmacy.

Yifeng Pharmacy Daily Average True Range (ATR) ChartYifeng Pharmacy Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Yifeng Pharmacy.

Yifeng Pharmacy Daily On-Balance Volume (OBV) ChartYifeng Pharmacy Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Yifeng Pharmacy.

Yifeng Pharmacy Daily Money Flow Index (MFI) ChartYifeng Pharmacy Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Yifeng Pharmacy.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Yifeng Pharmacy Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Yifeng Pharmacy based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose25.520
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Yifeng Pharmacy with someone you think should read this too:
  • Are you bullish or bearish on Yifeng Pharmacy? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Yifeng Pharmacy? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Yifeng Pharmacy

I send you an email if I find something interesting about Yifeng Pharmacy.


Comments

How you think about this?

Leave a comment

Stay informed about Yifeng Pharmacy.

Receive notifications about Yifeng Pharmacy in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.